Introduction {#Sec1}
============

One of the most common questions concerning sleep is: "how much should we sleep?" Several systematic reviews on sleep duration and mortality have found that the optimal sleep duration is 7 h, with a significant increase of overall mortality for individuals with short (≤6 h) or long (\>8 h) sleep \[[@CR1]--[@CR3]\]. In a critical review Kurina et al. \[[@CR4]\] argue that results from the literature are not totally consistent. The analysis of Kurina et al. \[[@CR4]\] included 42 studies, giving rise to 55 different estimates of the association between sleep duration and overall mortality, based on which only 14 studies (25%) showed a U-shaped relationship, while 23 studies (43%) showed no association at all, and the remainder showed associations for either short or long sleep. Their main arguments against the presence of a U-shaped relationship between sleep and mortality are the heterogeneity in the measurement of sleep duration and in its categorization, the use of different methods and variables for adjusting for potential confounders across studies, and different age ranges.

Since sleep duration decreases with age \[[@CR5]\], age may be a confounder of particular interest. Indeed, most studies adjust for it, but the role of age as potential effect modifier has not been explicitly studied other than in a few studies \[[@CR6]\]. Thus, Yeo et al. \[[@CR7]\] and Gangwish et al. \[[@CR8]\] reported that individuals older than, or equal to 60 years, had a U-shaped relationship between sleep duration and mortality, but the same pattern could not be found in those below the age of 60. Hublin et al. \[[@CR9]\] found a similar U-shaped pattern for men aged 55 years or older, but this was not seen in women in the same age group. For men younger than 55 years only short sleep was significantly associated with mortality. Two meta-analyses have investigated the effect of age on the relationship between sleep duration and mortality. Cappuccio et al. \[[@CR1]\] divided studies into those based on old (≥60 years) or young (\<60 years) cohorts, and demonstrated a U-shaped relationship between sleep duration and mortality in both types of cohorts. Liu et al. \[[@CR10]\] used 65 year as cut-off to categorize the included studies and showed a significant association between both short and long sleep and the risk of overall mortality among subjects \<65 years. Only long sleep duration was associated with an increased risk in participants ≥65. It is worth noting that none of the studies included stratification on age. As a consequence, there is a need for a systematic investigation of the role of age in the relationship between sleep duration and mortality.

The results from the meta-analyses seem to indicate that the U-shaped relationship may be found in all age groups, but nothing is known about more detailed effects of age. Most of the reported original studies are small, and it is not entirely clear why the 60-year cut-off is the most frequently used. One particular problem is that the age group above the age of 60 years will include a mixture of retirees and individuals still in the workforce. Retirement may lead to a different sleep pattern, since there is a possibility for "sleeping in" and nap during weekdays. Possibly, the 65-year cut-off (based on the common retirement age) would provide more homogeneous age groups in terms of sleep patterns.

Daytime napping will increase the total amount of sleep during a 24 h period, and should therefore be of interest when studying effects of sleep duration. Among the few available studies, Lan et al. \[[@CR11]\] adjusted for nap duration, which did not affect the results on sleep duration and mortality. Cohen-Mansfield et al. \[[@CR12]\] found that 9 h sleep plus napping was associated with increased mortality. The meta-analysis of Liu et al. \[[@CR10]\] found a pronounced J-shaped relationship between 24 h sleep duration (including naps) and all cause mortality. However, when night sleep (without naps) was considered, an increased risk was observed only for long sleep. Thus, napping may be an important variable in studies of sleep duration and mortality.

The main purpose of the present study was to quantify the relationship between sleep duration and subsequent mortality, while stratifying on age according to the retirement age cut-off. In addition, we studied how the relationship between sleep duration and mortality was affected by age, in a time dependent analysis.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

In September 1997 a fund-raising event organized by the Swedish Cancer Society ("the Swedish National March") took place on 3600 sites throughout the country. Participants were asked to fill out a 36-page questionnaire concerning lifestyle and medical history \[[@CR13], [@CR14]\]. The study was approved by the Regional Ethical Review Board of Karolinska Institutet, and all subjects provided informed consent. A total of 43,880 individuals returned the questionnaire. We excluded participants with clearly inconsistent answers (n = 4) and subjects who reported an incorrect national registration number (n = 13). Out of the remaining 43,863 subjects we excluded those with missing data on age (n = 11), had an age \<18 (n = 1740), or who had emigrated (n = 457), or died (n = 8) before the start of follow-up. We also excluded individuals with missing values on sleep duration (n = 2456). The final analysis included 14,024 men and 25,167 women for a total of 39,191 subjects.

Exposure assessment {#Sec4}
-------------------

The Karolinska Sleep Questionnaire (KSQ) was used to assess sleep characteristics \[[@CR15]\]. The questions included the following: "How many hours, approximately, per night do you usually sleep during a weekday night?" The initial response alternatives were: \<5, 5, 6, 7, 8, or ≥9 h. Because of insufficient number of participants in the shortest and longest sleep categories the two lowest and two highest categories, were collapsed. This yielded 4 categories: ≤5, 6, 7 (reference) and ≥8 h, with the extremes reflecting short and long sleep. The reference category was set to 7 h, since that was the most used reference in the meta-analysis by Cappuccio et al. \[[@CR1]\], as well as being the reference category in the largest study on sleep duration and mortality, in which more than one million participants were included \[[@CR16]\]. In addition, in this large study the observed difference in mortality between 7 and 8 h was significant.

Case ascertainment {#Sec5}
------------------

All-cause mortality data were obtained through linkage, using the Swedish National registration number, to the Swedish Cause of Death Register held by the National Board for Health and Welfare. A total of 3548 deaths (1940 men and 1608 women) occurred during 13 years of follow-up (September 1997--December 2010). Main causes of death were cardiovascular diseases (CVD-ICD-10 codes I00-I99) (n = 1140) and cancer (ICD-10 codes C00-C97) (n = 1645).

Statistical analysis {#Sec6}
--------------------

Baseline characteristics of the study cohort were described according to the four categories of sleep duration. The distribution of all variables, except age and sex, was directly standardized to the age distribution of the entire study population. Differences in baseline variables across categories of sleep duration were statistically assessed using the Student t-test for continuous variables and the Chi square test for categorical variables.

Based on our a priori assumptions on the relationships between confounders, intermediate variables, exposure, and outcome variables, we were able to draw a directed acyclic graph (DAG) \[[@CR17]\], with the aim to identify the minimal set of variables to adjust for the total effect (presented as supplementary material). To draw the DAG, the web-based application DAGitty (<http://www.dagitty.net>) was used \[[@CR18]\].

The association between sleep duration and mortality (overall, CVD mortality and cancer mortality) was assessed through a Cox proportional hazards regression model with attained age as time scale. To estimate hazard ratios (HR) and 95% confidence intervals (CI) age-adjusted and multivariable adjusted Cox models were computed. In the multivariable analyses we first controlled for the following potential confounders: sex, body mass index (BMI) (≤25, 25--30, ≥30 kg/m^2^), level of education (9, 11--14, ≥15 years, other), smoking status (never, former, current), alcohol consumption (quintiles of alcohol g/month: \<23, 23--124, 124--263, 263--503, ≥503), total physical activity (low ≤34.3, medium 34.3--46.4, high ≥46.4 MET \* hours/day, where MET stands for Metabolic Energy Turnover \[[@CR19]\]) and major diseases (CVD or cancer diagnosis before October 1997, obtained from the Swedish Patient Register). In addition, two more variables suggested by the DAG were considered, namely occupational status (employed, unemployed, retired, sick leave, other) and depression, based on the combination of the following five variables: feel sad, feel lonely, feel worried, feel unsatisfied, feel unhealthy (never, sometimes, often, always), each reclassified into two groups, often or always indicating presence of the condition; depression was considered present when at least three out of the five conditions were present. However, these two variables were not included due to a large proportion of missingness and degree of potential misclassification and included only in the sensitivity analysis.

We performed stratified analyses (together with a formal test for interaction) to assess the role of sleep duration within two different age groups separated at the retirement age in Sweden (\<65, ≥65). In order to investigate whether napping would change the relationship between sleep duration and mortality, the analyses were also stratified by napping ("never", "seldom" or "sometimes" vs. "most of the time" or "always").

The proportional hazards (PH) assumption of the covariates fitted in Cox's regression was tested using both Martingale's and Schoenfeld's residuals. Stratified Cox models were used to adjust for variables that did not meet the PH assumption, while predictors for which the PH assumption was satisfied were controlled by including them in the model.

Due to departures from the underlying proportional hazards assumption in the exposure of interest, a simple graphical tool based on restricted cubic splines \[[@CR20]\] was applied and graphs of the time-varying hazard ratio for short and long sleep are reported. The time-dependent coefficients for short and long sleep were modelled using restricted cubic splines with 3 knots placed according to Harrell's recommended percentiles (10th, 50th, and 90th of the distribution of the uncensored event times) \[[@CR21]\].

The proportional hazard assumption was violated only by the "major diseases" predictor, and therefore stratified Cox models were fitted throughout the study.

To explore the time dimension of the association between sleeping and mortality we used Laplace regression. This technique allows estimations of the differences in age at death, as a function of the covariates of interest, for each relevant percentile of the age distribution \[[@CR22]\]. We applied Laplace regression to estimate the 25th, 50th, and 75th percentiles of age at death, and we adjusted for the same set of confounders as in our main analysis. The Laplace models were further adjusted for baseline age, which was the time scale in the Cox models.

Subjects dying in the first 2 years of follow-up might have been sicker with undiagnosed diseases at the start of follow-up. To deal with this issue of reverse causality we performed a sensitivity analysis excluding the first 2 years of follow-up. Furthermore, we performed sensitivity analyses by additionally adjusting our model for occupational status, depression, snoring; moreover, we also adjusted by self-reported sleep medication use and napping which were considered as mediators in the proposed DAG. As sensitivity analysis, we drew a secondary DAG (graph not shown), including sleep quality and sleepiness. Both variables turned out to be part of the minimal set of covariates we needed to adjust for in order to estimate the total effect of sleep duration on mortality. These were thus added in the main model.

Sleep quality was defined as "good" or "rather good" versus "neither good nor bad", "rather bad" or "bad"; while sleepiness was defined as being "mostly" or "always" sleepy during the day versus "sometimes", "seldom" or "never" sleepy.

Lacking a consensus on what should be a proper reference category, we also used 7--8 h as reference, since that was the second most common reference value in the meta-analysis of Cappuccio et al. \[[@CR1]\]. The age cut-point of 65 years was based on the common retirement age in Sweden. However, since the present work focuses on age effects we also explored a very low cut-point (45 years) and a higher cut-point (70 years). In addition, we also applied a cut-point of 60 years since most of the few original studies that have analyzed age effects have used 60 years.

Analyses were performed using Stata, version 14 (StataCorp LP, College Station, Texas). All statistical tests were two-sided, and *p* values less than 0.05 were considered statistically significant.

Missing data {#Sec7}
------------

We first studied the distribution of age, sex, BMI, educational level, smoking, alcohol consumption, physical activity, and presence of major diseases among individuals with (n = 39,191) and without (n = 2456) exposure data (sleep duration during working week).

In order to study if exclusion of subjects with missing values would have resulted in overestimation of the true survival of the cohort, we estimated survival curves in subjects with and without missing exposure. Survival curves were adjusted for the before mentioned variables and were obtained through flexible parametric survival models, with follow-up time as time-scale \[[@CR23]\].

The proportion of missing values was 14.9% for occupational status, 7.7% for smoking status, 6.4% for physical activity, 4.1% for BMI, 1% for educational level and less than 1% for alcohol consumption, napping, snoring, hypnotics and depression. We assumed that data were missing at random (MAR). Multiple Imputation Chained Equation (MICE) with 20 imputations was used to impute missing data on covariates \[[@CR24]\]. The variables in the model were the same as the ones appearing in the complete-data model including information on survival outcomes (Nelson-Aalen cumulative hazard and mortality status).

Results {#Sec8}
=======

Table [1](#Tab1){ref-type="table"} shows the distribution of background variables across the groups defined by sleep duration. The participants with short sleep duration were on average older, more frequently men, less educated, and had a higher physical activity level. Participants with a longer sleep duration were less depressed, had a lower intake of coffee, and used less sleep medications. Background data stratified by age are presented as supplementary data (Table S1). Figure [1](#Fig1){ref-type="fig"} shows sleep duration across 5-year age groups. A regression analysis shows that there is a significant reduction in sleep duration as age increases (β = −0.037 h per 10 years (95% CI −0.043 to −0.030), R^2^ = 0.003), but the change is very small.Table 1Age-standardized baseline characteristics by categories of sleep duration in the Swedish National March CohortCharacteristicSleep duration, hours/day≤5 h6 h7 h≥8 hTotal sampleNo.%No.%No.%No.%No.%N3270919216822990739191Years at risk, mean (SD)12.4 (2.5)12.7 (2.0)12.8 (1.8)12.6 (2.3)12.7 (2.1)Deaths, n486761125510463548Cause specific deaths CVD^a^18037.023130.337329.735634.0114032.1 Cancer18037.036447.863250.446944.8164546.4 Suicide71.5121.6171.3121.2481.3 Respiratory disease214.3243.2564.5313.01323.7 Neurological disease132.7273.6362.9373.51133.2 Other8517.510313.514111.214113.547013.3Age, mean (SD)55.2 (16.5)50.5 (15.2)49.7 (15.0)50.8 (17.0)50.6 (13.3)Gender, males125238.3358939.0597035.5321332.41402435.8BMI, mean (SD)25.2 (4.0)24.7 (3.6)24.5 (3.4)24.6 (3.5)24.6 (3.5)Education 9 years154142.7329236.6576135.8384238.91443637.2 11--14 years106035.6308034.1539532.2327433.01280933.0 15 years59520.8265028.6541731.4261427.41127629.1 Other340.9690.71030.6760.72820.7Employment Employed127858.7514464.2933663.7390956.51966761.8 Unemployed703.11532.02741.92783.67752.4 Retired118224.9193524.1335524.8294827.0942025.2 Sick leave1034.31111.51801.32273.26212.0 Other2339.06018.211118.39239.728688.6Snoring Frequent3079.77448.111506.97147.429157.5 Infrequent239574.8715678.21360180.9803881.63119080.0 Uncertain53515.5124013.7199212.2109711.0486412.5Good sleep quality149047.3679074.21493289.2915592.73236783.11Daytime sleepiness50517.48589.59515.75665.528807.4Work schedule Daytime130049.3525457.91046061.8497356.52198758.7 Shiftwork46018.6125313.916759.87738.8416111.1 Other772.91862.32891.91771.87292.0 No work103529.2183125.9332726.5308032.9927328.2Smoking Never184060.7515361.71005864.9607164.92312263.9 Former79127.4249628.9444328.0245328.01018328.2 Current29511.98129.411517.16157.128737.9Alcohol g/month 0--23 g79222.2165518.4321519.8224222.1790420.0 23--124 g62119.8177419.4327419.4204820.8771720.0 124--263 g60218.5178619.4341920.2200020.3780720.0 263--503 g56517.6196521.3350220.6177018.3780220.0 \>503 g67321.9197321.5336120.0180018.5780720.0Self-reported health Very good55818.5227825.1474428.5270628.11028626.8 Good161851.0504656.2929556.6533155.02129055.7 Average75623.5144216.2208312.9133613.7561714.7 Poor1816.12002.23001.82592.89402.5 Very poor260.9280.3320.2440.41300.3Physical activity Low110335.1362042.2679442.9447648.71599343.6 Medium101834.2295634.4572635.8306333.01276334.8 High89830.7198423.4332221.3173318.3793721.6Coffee intake, cups/day None31411.097211.2206812.6149714.2485112.7 1--3169949.7448950.0878053.3528154.22024952.5 4--6102333.0311933.8518030.9270428.81202631.1 ≥71616.34645.05513.22512.814273.7Nap during day3158.16267.110697.0108010.230907.9Hypnotics95125.4139015.4164710.399710.0498512.8Diabetes1283.52222.63332.22512.69342.5Depression55818.799310.811947.07227.434678.9Major diseases^b^67716.5138415.4229414.6163215.8598715.3^a^Cardiovascular disease^b^Diagnosis of cardiovascular disease or cancer before October 1997 Fig. 1Weekday sleep according to age in 5-year intervals. Mean ± SD

Table [2](#Tab2){ref-type="table"} shows the estimated hazard ratios for the relationship between sleep duration and total mortality, both for the entire cohort, and stratified by age. Subjects with short and long sleep duration showed a higher mortality, not statistically significant in the entire cohort. However, sleep duration did not satisfy the PH assumption, which means that the effect of sleep duration on mortality was significantly different across ages \[[@CR25]\]. This difference in HR across ages was explored in Fig. [2](#Fig2){ref-type="fig"}, which shows that the estimated time varying HRs decreased with increasing age. As expected from the PH assumption test on the exposure, the interaction between sleep duration and age as binary was highly significant (*p* value 0.006) and in the age stratified analyses the PH assumption was satisfied in both age groups. Mortality was significantly higher among individuals below the age of 65 with ≤5 and ≥8 h of sleep compared to 7 h. No significant results were seen for participants ≥65 years. Occupational status, depression, snoring, sleep medication use, napping, sleep quality and sleepiness did not affect the results appreciably and were thus left out of the main analysis (data not shown).Table 2Sleep duration and mortality: overall and age stratified analysisSleep duration, hours/dayCrudeMultivariable adjusted^a^No. of deathsPerson-yearsHR95% CINo. of deathsPerson-yearsHR95% CI ≤5 h48640,4691.131.01, 1.2533731,5711.120.99, 1.27 6 h761116,9381.000.92, 1.1056495,9170.980.88, 1.09 7 h1255215,2221.00Referent984181,8151.00Referent ≥8 h1046124,4831.151.05, 1.24805103,3521.101.00, 1.20Age \<65 ≤5 h12728,1191.451.19, 1.779822,4091.371.09, 1.71 6 h26296,8750.990.85, 1.1521180,5960.920.77, 1.08 7 h482181,2931.00Referent396154,2721.00Referent ≥8 h34095,7641.321.15, 1.5227080,0511.271.08, 1.48Age ≥65 ≤5 h35912,3501.020.90, 1.1623991621.050.90, 1.22 6 h49920,0631.010.90, 1.1335315,3211.030.90, 1.17 7 h77333,9301.00Referent58827,5421.00Referent ≥8 h70628,7191.060.96, 1.1853523,3011.010.90, 1.14^a^Hazard ratios were adjusted for age, sex, BMI, smoking status, alcohol consumption, educational level, physical activity and major diseases. Attained age was used as time scale Fig. 2Mortality expressed as time-varying Hazard ratios and 95% confidence intervals for short (**a**) and long (**b**) sleepers versus the 7-h reference group

When stratifying on napping, no significant results were found. However, results stratified both on age and napping showed that long and short sleepers, younger than 65 who did not report napping during the day, retained their original, significant results, while no significant results appeared in the older groups (data not shown).

As a sensitivity analysis we repeated the main analysis (fully adjusted), with the category ≥8 h split into the original 8 and ≥9 h categories, respectively. For the \<65 year group, the 8 h category (250 deaths) remained essentially unchanged with HR 1.28 (95% CI 1.09; 1.50), while the ≥9 h category (20 deaths) showed an HR 1.11 (95% CI 0.71; 1.74). No differences in mortality rates were seen in the oldest age group. A sensitivity analysis was also carried out to test the effect of sleep duration on mortality when using 7--8 h (646 deaths) as reference. Among subjects \<65 years the results (fully adjusted) showed an increased mortality for the ≤5 h category only, with an HR 1.25 (95% CI 1.01, 1.55). Sleeping 6 h showed a HR of 0.84 (95% CI 0.72--0.98), while no increased mortality was detected for the ≥9 h category (HR 1.01, 95% CI 0.65, 1.58). No significant results were observed for the same analysis in the ≥65-year group.

For the relationship between sleep duration and cause-specific mortality, and its link to age, we did not observe any significant pattern for the overall group or among subjects above the age of 65 years. Table [3](#Tab3){ref-type="table"} shows the results from cause-specific mortality due to CVD and cancer exclusively for subjects \<65 years of age. CVD mortality was significantly increased among individuals with long sleep duration. For cancer, no evidence of significant associations was found after full adjustment.Table 3Sleep duration and cause specific mortality for subjects \< 65 yearsSleep duration, hours/day\<65 yearsCrudeMultivariable adjusted^a^No. of deathsPerson-yearsHR95% CINo. of deathsPerson-yearsHR95% CICVD mortality ≤5 h2228,1191.400.87, 2.241822,4091.410.83, 2.37 6 h4496,8750.960.66, 1.383380,5960.840.56, 1.28 7 h83181,2931.00Referent66154,2721.00Referent ≥8 h6695,7641.451.05, 2.015580,0511.541.07, 2.21Cancer mortality ≤5 h7328,1191.250.97, 1.615622,4091.130.83, 1.53 6 h16396,8750.920.76, 1.1113280,5960.860.70, 1.07 7 h323181,2931.00Referent271154,2721.00Referent ≥8 h21295,7641.251.05, 1.4816880,0511.160.94, 1.42^a^ Hazard ratios were adjusted for age, sex, BMI, smoking status, alcohol consumption, educational level, physical activity and major diseases. Attained age was used as time scale

To explore the age effect further, time varying HRs are graphically reported in Fig. [2](#Fig2){ref-type="fig"}. The HRs for both short and long sleep present a decreasing pattern with respect to age, being greater than 2 in the youngest and equal to 1 or even below, in the oldest. The age span of significant excessive mortality for short sleepers was 41.0--74.5 years. This represents 70.9% of the sample, with 19.1% below and 10.0% of the sample above the span. For long sleepers the corresponding age span was 27.0--75.5 years, while a reduced mortality was observed beyond 88.6 years. The age span with higher mortality represents 82.9% of the sample, with 13.3% below and 3.7% of the sample above the span, but below 88.6 years. Only 0.1% of the long sleepers was above this age.

To complement the results from the previous analysis, multivariable Cox regressions were run by stratifying on two different cut points (45 and 70 years). In both cases significant results were observed only in the category including the younger subjects. In those below 45 years the HR was 2.45 (95% CI 1.19--5.04) for short sleep (≤5 h) and 2.10 (95% CI 1.32--3.34) for long sleep. In those below 70 years the corresponding HR values for short and long sleep were 1.38 (95% CI 1.16--1.65) and 1.20 (95% CI 1.06--1.36), respectively. Finally, we also used the standard 60-year cut-point, given that it has been used in the few studies that have been carried out on age effects. This yielded results very similar to those with the cut-point at 65 years. See Table S2.

The influence of age was also examined by using Laplace regression to estimate different percentiles of the distribution of age at death. Table [4](#Tab4){ref-type="table"} shows that at the 25th percentile of age at death, short and long sleepers died 8.5 (95% CI −16.7; −0.4) and 6.6 months (95% CI −12.4; −0.7) earlier, respectively. Smaller estimates and no significant relationships were seen for the other age percentiles, denoting a stronger effect of sleeping among subjects who died younger.Table 4Differences in months in age at death across levels of sleep duration in the Swedish National March CohortSleep duration, hours/dayNo. of deathsPerson-years25th PD, months50th PD, months75th PD, monthsPD95% CIPD95% CIPD95% CIModel 1^a^ ≤5 h48640,469−8.8−15.3, −2.3−6.7−12.9, −0.5−7.0−12.8, −1.2 6 h761116,938−0.5−5.9, 4.9−0.3−5.5, 4.8−0.9−6.0, 4.1 7 h1255215,2220Referent0Referent0Referent ≥8 h1046124,483−9.5−14.7, −4.4−6.9−11.5, −2.2−6.9−11.5, −2.2Model 2^b^ ≤5 h33731,571−8.5−16.7, −0.4−6.2−13.2, 0.9−6.5−13.4, 0.4 6 h56495,9171.4−4.8, 7.71.7−4.2, 7.60.2−5.5, 5.8 7 h984181,8150Referent0Referent0Referent ≥8 h805103,352−6.6−12.4, −0.7−5.3−10.6, 0.1−3.6−9.1, 1.9*PD* percentile difference^a^Estimates were obtained by fitting a Laplace regression on the 25th, 50th, and the 75th percentiles of age at death adjusted for age at baseline^b^The model was further adjusted for sex, body mass index, smoking status, alcohol consumption, educational level, physical activity and major diseases

After excluding cases occurring in the first 2 years of follow-up, only minor changes in the results were observed. For subjects \<65 years we confirmed a statistically significant association between sleep duration and mortality (for ≤5 h of sleep, HR 1.31, 95% CI 1.03--1.65; for ≥8 h of sleep, HR 1.23, 95% CI 1.05--1.45). For subjects aged 65 or older no statistically significant association was detected.

We lacked information on sleep duration for 2456 subjects. These were older, less educated and with more health problems. By comparing the adjusted survival curves of individuals with and without information on the exposure, no difference in survival was observed. As a result, when eliminating subjects with missing values on sleep duration from the analysis, the true survival of the cohort ought not be overestimated.

The results obtained using the imputed dataset are similar to those after excluding subjects with missing values on covariates: with 7 h as reference the estimates among the youngest (\<65 years) were 1.38 (95% CI 1.13--1.68) for short sleep and 1.29 (95% CI 1.12--1.48) for long sleep. No significant association was detected among the oldest (≥65 years) (for ≤5 h HR 1.07, 95% CI 0.94--1.22; for ≥8 h, HR 1.02, 95% CI 0.92--1.13).

Discussion {#Sec9}
==========

In this large, prospective cohort, individuals younger than 65 years, who at baseline reported either short or long sleep duration, showed an increased mortality. In those aged 65 or older, there was no significant association between sleep duration and mortality. The effect of sleep duration on mortality was highest among young individuals and decreased with increasing age. The quantile regression analysis supported this finding.

The U-shaped relation between sleep duration and mortality essentially agrees with previous meta analyses \[[@CR1]--[@CR3], [@CR10]\], except for Liu et al \[[@CR10]\], who found a J-shaped one.

Still, the present results deviate from the meta-analyses of Cappuccio \[[@CR1]\] and Silva \[[@CR3]\] in which, in contrast to our findings, a clear effect of sleep duration in individuals ≥60 years was shown. This relationship was also supported by three original studies \[[@CR7]--[@CR9]\], whereas Liu et al. \[[@CR10]\] in their meta-analysis did find an increased effect for long sleep but not for short sleep in individuals \>65 years.

However, if the decrease in HR with age is a correct conclusion, then the strength and the significance of the effect of sleep duration on mortality will depend on the proportion of older participants in the study. The larger the proportion, the less the likelihood would be of a significant result. Thus, varying proportions of older participants in different studies could contribute to the variability in conclusions found in the literature. In the present cohort, the proportion of individuals ≥75 years (at which point the HR was no longer significantly above unity) among participants aged 65 or older was 19%. Corresponding proportions are not available from other studies.

The observed decline in the hazard ratio as a function of age is a new finding and there is no clear explanation for this decreasing pattern. However, the spectrum of causes of death changes with age and this may dilute any effect of sleep duration on mortality in higher age groups. Another explanation of the lack of effect of sleep duration in higher age groups may be that older individuals represent a survivor population that may be particularly resilient to negative health effects. A third explanation may be the effects of being retired on the precision of estimations of sleep duration. Not having to rise at a certain time to go to work could deprive the individual of an important time reference. This loss of reference may reduce the precision of estimates of sleep duration and thus result in misclassification of the exposure and in a weaker association between sleep duration and mortality. This issue does not, however, seem to have been formally investigated. It should be emphasized that there was very little change in sleep duration across age groups (1.2 min per year), suggesting that mean sleep duration is unlikely to be a part of the loss of relationship between sleep duration and mortality with increasing age.

Our original hypothesis was that the decreased sleep duration with age \[[@CR5]\] would result in a stronger link to mortality for long sleepers, because long sleep would deviate from the norm. Similarly, short sleep in younger individuals was expected to lead to increased mortality, again because short sleep would deviate from the age norm. These hypotheses were not confirmed; rather it seems that long and short sleep have similar relationships with mortality regardless of age group and that the association disappears in higher age groups. In fact, inspection of Fig. [2](#Fig2){ref-type="fig"} shows that mortality hazard ratio falls below unity above the age of approximately 87 years. This might be a spurious result based on rather few deaths. It might possibly also indicate that with increasing age, the ability to produce long sleep might be an indication of good health. Addressing this interesting age issue will require a larger sample in higher age groups than what is available in the present study.

The explanation of the U-shaped relationship between sleep duration and mortality has been discussed in most previous work in this area. Conditions like comorbidities, BMI, alcohol consumption, education, employment status, work schedules, snoring, physical activity, napping, use of hypnotics, depression, sleep quality, sleepiness and snoring were considered and adjusted for in the present study, or tested separately, and should not have affected outcomes. Grandner et al. \[[@CR6]\] suggested that sleep loss might have similar effects to those caused by low grade inflammation and that increased levels of ghrelin, increased lipid levels, and insulin resistance could be involved in this process. The mechanism involved in the association between long sleep and mortality still defies speculation, apart from the possibility of residual confounding or undetected diseases.

The reason for the lack of effect of napping may be that napping was rarely reported in the present cohort, particularly in younger individuals. Furthermore, we did not collect information on the duration of the naps, which is a limitation. Still, the few previous original studies on napping do not provide any clear conclusions \[[@CR11], [@CR12], [@CR26]\]. Leaving out napping resulted in a lack of significant effect for short sleep in the meta regression of Liu et al. \[[@CR10]\]. Still, the role of napping in relation to mortality remains unclear.

The sensitivity analysis using different cut-offs for sleep duration showed that long sleep defined as ≥9 h yielded a non-significant hazard ratio in both age groups. The reason for this is not clear, but the number of deaths in subjects below the age of 65 in this sleep category was very low (20), as was the number of person-years (6379). This invites chance effects -- only a few more deaths would have increased the estimate for the hazard ratio, albeit with large confidence intervals. Short sleep (≤5 h), the second smallest category, contained 5 times as many deaths and 3.5 times as many person-years.

Using 7--8 h of sleep as reference and defining long sleep as ≥9 h had two consequences. Firstly, long sleep duration was not significant and the point estimate became closer to one. It's likely that the higher mortality in the 8 h category raised mortality above the level of that of 7 h of sleep, thus reducing the difference between the reference and the ≥9 h category. Secondly, for the same reason, the 6 h category showed a significant HR below 1. It was also associated with the lowest mortality in the original analysis with 7 h as reference, but the estimated HR, despite being below 1, was not significant. These results might suggest that, in the present cohort, the optimal sleep duration with respect of mortality is 6 h, rather than 7 h.

The strengths of the present study are its size, the length of the follow-up, the ability to directly link baseline information with mortality registers through the national registration number and the high quality of the data. However, as with virtually all studies of sleep duration, it relies on self-reported information. This is clearly a weakness, but one which is shared with many other exposure variables in the field of lifestyle epidemiology. Though, it has been found a strong correlation between the average sleep measured through 7-day diaries and that obtained from one sleep-duration question \[[@CR27]\] with small systematic bias caused by a tendency of overestimation \[[@CR28]\].

Similarly, most confounders are also self-reported. One confounder not included was sleep apnea, however, we did adjust for snoring, which is probably a reasonable proxy. Another limitation of our study concerns the measurement of the exposure only at baseline, thus potential changes in sleep duration during follow-up would go undetected.

Major disease is generally seen as the most crucial variable to adjust for in studies of sleep duration and mortality. This was done in the present study, however, precursors of major diseases (such as increased levels of lipids or blood sugar) could also play a role, but this information was not available. Kurina et al. \[[@CR4]\] have remarked that major diseases, not yet diagnosed, may be an important contributor to unreliable results. To minimize the risk of reverse confounding, we excluded cases occurring in the two first years of follow-up, but the results remained virtually unchanged.

Kurina et al. \[[@CR4]\] also pointed out that an important issue is the subjective estimate of sleep duration. This may be a problem, but it does not seem likely that individuals who are healthy at baseline would misclassify their sleep duration to a higher degree based on future mortality. Van den Berg et al \[[@CR29]\], however, found that subjective estimates of sleep duration differed more from objective ones depending on sleep quality, gender, poor cognitive function and functional disability. We adjusted for the two first, but the two latter variables may have affected the estimates of sleep duration, particularly among the older participants. This could have contributed to the lack of significant association between sleep duration and mortality in the older group. It should be emphasized that in the present study, as in most other studies \[[@CR30]\], we analyzed weekday sleep, which means that sleep was restricted by work for most individuals. Possibly, weekend sleep may also be of interest for studying the relationship between sleep duration and mortality.

In conclusion, the present study showed that increasing age reduces the relationship between sleep duration and mortality and that the relationship is particularly strong in younger individuals.
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